Want to join the conversation?
$VRX said it has restored net profitability to new dermatology prescriptions starting on Aug. 5, 2016, which will improve the overall derm selling price. The company launched a new prior authorization process with its partner Walgreens on Aug.4, which should improve the adjudication experience.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?